Using blood biomarkers to assess heart disease risk

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to explore the relationship between serum biomarkers and coronary artery disease (CAD) using multidetector computed tomography (CT). Patients referred for routine coronary CT angiography (CCTA) will have their venous blood sampled to identify potential biomarkers associated with atherothrombosis. The goal is to improve risk stratification for patients at risk of major adverse cardiac events (MACE) by utilizing these biomarkers. This approach could provide a cost-effective method for identifying individuals at higher risk for cardiovascular issues.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients referred from the Cardiology clinic for routine CCTA.

Exclusion Criteria:

* Pregnancy
* Severe renal insufficiency
* Severe allergy to contrast medium
* Inability to obtain informed consent
* Age below 18 years

Where it's running

• Maastricht University Medical Center
  Maastricht, Limburg, Netherlands Recruiting

Study contacts

• Principal investigator: Bas Kietselaer, MD, PhD — Maastricht University Medical Center
• Study coordinator: Bas Kietselaer, MD, PhD
• Email: b.kietsealer@mumc.nl
• Phone: +31433871587

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Pudendal artery plaque and erectile dysfunction in men with heart disease

  A small study tests whether plaque in the internal pudendal arteries is linked to erectile function in men with coronary artery disease who are undergoing coronary angiography.

  Recruiting Hospital Central Militar · Mexico City, Mexico City · NCT07856199

• Dapagliflozin to slow coronary plaque progression in type 2 diabetes

  This trial tests whether adding dapagliflozin to standard care can slow or reverse coronary plaque buildup in adults with type 2 diabetes and stable coronary disease.

  Recruiting at 2 sites Phase 4 Chinese PLA General Hospital · Beijing, Beijing Municipality and 1 other locations · NCT07614230

• YN001 in adults with coronary atherosclerosis

  A randomized, placebo-controlled study tests whether IV YN001 can help people with coronary plaque and heart risk factors see if their plaques stabilize or shrink.

  Recruiting at 35 sites Phase 2 Beijing Inno Medicine Co., Ltd. · Huntsville, Alabama and 55 other locations · NCT07521007

• Software that analyzes heart CT scans to detect coronary artery disease

  This project will test a new software that uses past coronary CT scans to see if it can accurately find blockages and predict which patients might need procedures.

  Recruiting at 4 sites Instituto de Investigación Biomédica de Salamanca · Villeurbanne and 3 other locations · NCT06977295

• Exercise training for patients with coronary artery disease

  This study tests if a 12-week exercise program can improve heart health for people aged 40-70 with coronary artery disease.

  Recruiting Instituto Nacional de Cardiologia de Laranjeiras · Rio de Janeiro, Rio de Janeiro · NCT06579807

• Single versus dual antiplatelet therapy after drug-coated balloon angioplasty in elderly or high-bleeding-risk patients

  This study tests whether taking one antiplatelet medicine is as safe and causes less bleeding than taking two medicines for people aged 75 or older, or adults at high bleeding risk, after drug-coated balloon angioplasty for coronary artery disease.

  Recruiting Fondazione Ricerca e Innovazione Cardiovascolare ETS · Milan, MI · NCT06535568

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.